110 related articles for article (PubMed ID: 12392719)
1. The effect of glycerol on cytochrome P450scc (CYP11A1) spin state, activity, and hydration.
Headlam MJ; Tuckey RC
Arch Biochem Biophys; 2002 Nov; 407(1):95-102. PubMed ID: 12392719
[TBL] [Abstract][Full Text] [Related]
2. Identification of intermediates in the conversion of cholesterol to pregnenolone with a reconstituted cytochrome p-450scc system: accumulation of the intermediate modulated by the adrenodoxin level.
Sugano S; Miura R; Morishima N
J Biochem; 1996 Oct; 120(4):780-7. PubMed ID: 8947841
[TBL] [Abstract][Full Text] [Related]
3. Evidence That Compound I Is the Active Species in Both the Hydroxylase and Lyase Steps by Which P450scc Converts Cholesterol to Pregnenolone: EPR/ENDOR/Cryoreduction/Annealing Studies.
Davydov R; Strushkevich N; Smil D; Yantsevich A; Gilep A; Usanov S; Hoffman BM
Biochemistry; 2015 Dec; 54(48):7089-97. PubMed ID: 26603348
[TBL] [Abstract][Full Text] [Related]
4. Role of positively charged residues lys267, lys270, and arg411 of cytochrome p450scc (CYP11A1) in interaction with adrenodoxin.
Strushkevich NV; Azeva TN; Lepesheva GI; Usanov SA
Biochemistry (Mosc); 2005 Jun; 70(6):664-71. PubMed ID: 16038609
[TBL] [Abstract][Full Text] [Related]
5. Complex formation in vesicle-reconstituted mitochondrial cytochrome P450 systems (CYP11A1 and CYP11B1) as evidenced by rotational diffusion experiments using EPR and ST-EPR.
Schwarz D; Chernogolov A; Kisselev P
Biochemistry; 1999 Jul; 38(29):9456-64. PubMed ID: 10413522
[TBL] [Abstract][Full Text] [Related]
6. Comparative structural and immunochemical characterization of recombinant and natural cytochrome p450scc (CYPXIAI).
Lepesheva GI; Usanov SA
Biochemistry (Mosc); 1998 Feb; 63(2):224-34. PubMed ID: 9526119
[TBL] [Abstract][Full Text] [Related]
7. Comparative study of topogenesis of cytochrome P450scc (CYP11A1) and its hybrids with adrenodoxin expressed in Escherichia coli cells.
Vinogradova AA; Luzikov VN; Novikova LA
Biochemistry (Mosc); 2007 Feb; 72(2):208-14. PubMed ID: 17367299
[TBL] [Abstract][Full Text] [Related]
8. Langmuir-Blodgett films of cytochrome P450scc and its complex with adrenodoxin.
Guryev OL; Dubrovsky TB; Chernogolov AA; Dubrovskaya SB; Nicolini C; Usanov SA
Biochemistry (Mosc); 1997 Jun; 62(6):641-7. PubMed ID: 9284546
[TBL] [Abstract][Full Text] [Related]
9. Analysis of In Vivo Activity of the Bovine Cholesterol Hydroxylase/Lyase System Proteins Expressed in Escherichia coli.
Efimova VS; Isaeva LV; Rubtsov MA; Novikova LA
Mol Biotechnol; 2019 Apr; 61(4):261-273. PubMed ID: 30729436
[TBL] [Abstract][Full Text] [Related]
10. Compound I is the reactive intermediate in the first monooxygenation step during conversion of cholesterol to pregnenolone by cytochrome P450scc: EPR/ENDOR/cryoreduction/annealing studies.
Davydov R; Gilep AA; Strushkevich NV; Usanov SA; Hoffman BM
J Am Chem Soc; 2012 Oct; 134(41):17149-56. PubMed ID: 23039857
[TBL] [Abstract][Full Text] [Related]
11. Formation and functioning of fused cholesterol side-chain cleavage enzymes.
Nazarov PA; Drutsa VL; Miller WL; Shkumatov VM; Luzikov VN; Novikova LA
DNA Cell Biol; 2003 Apr; 22(4):243-52. PubMed ID: 12823901
[TBL] [Abstract][Full Text] [Related]
12. Adrenodoxin-cytochrome P450scc interaction as revealed by EPR spectroscopy: comparison with the putidaredoxin-cytochrome P450cam system.
Takeuchi K; Tsubaki M; Futagawa J; Masuya F; Hori H
J Biochem; 2001 Dec; 130(6):789-97. PubMed ID: 11726279
[TBL] [Abstract][Full Text] [Related]
13. Comparative structural-functional characterization of recombinant and natural adrenodoxin. Interaction with cytochrome P450scc.
Lepesheva GI; Azeva TN; Strushkevich NV; Adamovich TB; Cherkesova TS; Usanov SA
Biochemistry (Mosc); 1999 Sep; 64(9):1079-88. PubMed ID: 10521726
[TBL] [Abstract][Full Text] [Related]
14. Placental cytochrome P450scc (CYP11A1): comparison of catalytic properties between conditions of limiting and saturating adrenodoxin reductase.
Tuckey RC; Headlam MJ
J Steroid Biochem Mol Biol; 2002 Jun; 81(2):153-8. PubMed ID: 12137805
[TBL] [Abstract][Full Text] [Related]
15. Probing the interaction of bovine cytochrome P450scc (CYP11A1) with adrenodoxin: evaluating site-directed mutations by molecular modeling.
Usanov SA; Graham SE; Lepesheva GI; Azeva TN; Strushkevich NV; Gilep AA; Estabrook RW; Peterson JA
Biochemistry; 2002 Jul; 41(26):8310-20. PubMed ID: 12081479
[TBL] [Abstract][Full Text] [Related]
16. Electronic and stereochemical characterizations of intermediates in the photolysis of ferric cytochrome P450scc nitrosyl complexes. Effects of cholesterol and its analogues on ligand binding structures.
Hori H; Masuya F; Tsubaki M; Yoshikawa S; Ichikawa Y
J Biol Chem; 1992 Sep; 267(26):18377-81. PubMed ID: 1326522
[TBL] [Abstract][Full Text] [Related]
17. Reconstruction of mitochondrial cytochrome P450-dependent steroid hydroxylases in artificial phospholipid membranes: studies of cytochrome P450scc topology by limited proteolysis.
Krivosheev AV; Usanov SA
Biochemistry (Mosc); 1997 Oct; 62(10):1064-73. PubMed ID: 9461629
[TBL] [Abstract][Full Text] [Related]
18. Human placental cholesterol side-chain cleavage: enzymatic synthesis of (22R)-20 alpha,22-dihydroxycholesterol.
Tuckey RC; Cameron KJ
Steroids; 1993 May; 58(5):230-3. PubMed ID: 8356576
[TBL] [Abstract][Full Text] [Related]
19. Oxidized adrenodoxin acts as a competitive inhibitor of cytochrome P450scc in mitochondria from the human placenta.
Tuckey RC; McKinley AJ; Headlam MJ
Eur J Biochem; 2001 Apr; 268(8):2338-43. PubMed ID: 11298752
[TBL] [Abstract][Full Text] [Related]
20. Selective chemical modification of Cys264 with diiodofluorescein iodacetamide as a tool to study the membrane topology of cytochrome P450scc (CYP11A1).
Chernogolov A; Usanov S; Kraft R; Schwartz D
FEBS Lett; 1994 Feb; 340(1-2):83-8. PubMed ID: 8119413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
